However, our results differed from those of other reports demonstrating SPARC staining mainly located in stromal cells17,20,21 and that SPARC overexpression in stromal cells surrounding the tumor cells was negatively correlated with clinicopathological factors17 and Ki-67 labeling index21. This evidence concerns the gene MKI67 and neoplasm.